计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| D608799-5mg |
5mg |
期货 ![]() |
| |
| D608799-25mg |
25mg |
期货 ![]() |
|
| 别名 | 8-[4-[2-[[2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚-4-基]氨基]乙酰基]哌嗪-1-基]-9-乙基-6,6-二甲基-11-氧代-5H-苯并[b]咔唑-3-腈 |
|---|---|
| 英文别名 | compound 17 |
| 规格或纯度 | Moligand™ |
| 英文名称 | 8-[4-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]acetyl]piperazin-1-yl]-9-ethyl-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile |
| 作用类型 | 抑制剂 |
| 作用机制 | ALK 受体酪氨酸激酶抑制剂 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 未知 |
|---|---|
| IIUPAC Name | 8-[4-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]acetyl]piperazin-1-yl]-9-ethyl-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile |
| INCHI | 1S/C40H37N7O6/c1-4-22-17-25-26(40(2,3)36-34(35(25)50)23-9-8-21(19-41)16-28(23)43-36)18-30(22)45-12-14-46(15-13-45)32(49)20-42-27-7-5-6-24-33(27)39(53)47(38(24)52)29-10-11-31(48)44-37(29)51/h5-9,16-18,29,42-43H,4,10-15,20H2,1-3H3,(H,44,48,51) |
| InChi Key | UMEMOEKJTJMMJN-UHFFFAOYSA-N |
| Smiles | N#Cc1ccc2c(c1)[nH]c1c2C(=O)c2c(C1(C)C)cc(c(c2)CC)N1CCN(CC1)C(=O)CNc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O |
| Isomeric SMILES | CCC1=CC2=C(C=C1N3CCN(CC3)C(=O)CNC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O)C(C7=C(C2=O)C8=C(N7)C=C(C=C8)C#N)(C)C |
| PubChem CID | 155142832 |
| 1. Xie S, Sun Y, Liu Y, Li X, Li X, Zhong W, Zhan F, Zhu J, Yao H, Yang DH et al.. (2021) Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK).. J Med Chem, [PMID:34176264] [10.1021/acs.jmedchem.1c00270] |